Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability of GSK3640254 Mesylate vs Hydrochloride Salt in Healthy Participants
NCT03575962Phase 1Completed
- Sponsor
- ViiV Healthcare
- Start
- Jun 2018
- Primary completion
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of fipravirimat in human immunodeficiency virus type 1 infection (HIV-1) (2 arms), sponsored by ViiV Healthcare. Primary endpoints: Area Under the Concentration-time Curve From Time Zero Extrapolated to Infinite Time, Area Under the Concentration-time Curve From Zero to Time of Last Sample Taken and 3 more. Started Jun 2018; status: completed.
02
Drugs
fipravirimat
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT03575962.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03575962.